Ruff Shamim

Director at REATA PHARMACEUTICALS INC; SVP, Regulatory Affairs & Qual at SRPT

Sold, on record
$3.9M
Dollars the filings state
Form 4 sales
6
Latest Jul 28, 2023
Form 144 notices
1
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale SRPTUnusual
    Sep 22, 2016 2016

    Sold 7,311 shares at $60.00 ($439k)

    Ruff Shamim, SVP, Regulatory Affairs & Qual

    Sold 26.5% of holdings ($1.7M position)20,239 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale SRPTUnusual
    Jul 21, 2017 +302 days

    Sold 10,638 shares at $42.82 ($456k)

    Ruff Shamim, SVP, Regulatory Affairs & Qual

    Sold 33.6% of holdings ($1.4M position)21,062 shares leftFiling

  3. 3 Form 4 sale SRPTUnusual
    Oct 3, 2017 +74 days

    Sold 11,500 shares at $50.00 ($575k)

    Ruff Shamim, SVP, Regulatory Affairs & Qual

    Sold 29.8% of holdings ($1.9M position)27,045 shares leftFiling

  4. 4 Form 4 sale SRPTUnusual
    Nov 6, 2017 +34 days

    Sold 10,000 shares at $55.00 ($550k)

    Ruff Shamim, SVP, Regulatory Affairs & Qual

    Sold 27% of holdings ($2M position)27,045 shares left0.9x usual sizeFiling

  5. 5 Form 4 sale REATA PHARMACEUTICALS INCUnusual
    Mar 10, 2023 +1950 days

    Sold 5,740 shares at $83.73 ($481k)

    Ruff Shamim, Director

    Sold 52.4% of holdings ($918k position)5,223 shares leftFirst sale on recordFiling

  6. 6 Form 144 notice REATA PHARMACEUTICALS INCNotice
    Jul 28, 2023 +140 days

    Filed to sell 8,235 shares ($1.4M)

    Ruff Shamim, Director

    10b5-1 planFiling

  7. 7 Form 4 sale REATA PHARMACEUTICALS INCRoutine
    Jul 28, 2023 same day

    Sold 8,235 shares at $164.53 ($1.4M)

    Ruff Shamim, Director

    10b5-1 planSold 52.8% of holdings ($2.6M position)7,359 shares leftFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (7)

Form 144 notices and Form 4 sales by Ruff Shamim
Source
Jul 28, 2023Aug 1, 2023REATA PHARMACEUTICALS INCDirectorForm 4 sale8,235$1.4M52.8%RoutineSEC
Jul 28, 2023Jul 28, 2023REATA PHARMACEUTICALS INCDirectorForm 144 notice8,235$1.4MNoticeSEC
Mar 10, 2023Mar 13, 2023REATA PHARMACEUTICALS INCDirectorForm 4 sale5,740$481k52.4%UnusualSEC
Nov 6, 2017Nov 8, 2017SRPTSVP, Regulatory Affairs & QualForm 4 sale10,000$550k27.0%UnusualSEC
Oct 3, 2017Oct 5, 2017SRPTSVP, Regulatory Affairs & QualForm 4 sale11,500$575k29.8%UnusualSEC
Jul 21, 2017Jul 21, 2017SRPTSVP, Regulatory Affairs & QualForm 4 sale10,638$456k33.6%UnusualSEC
Sep 22, 2016Sep 30, 2016SRPTSVP, Regulatory Affairs & QualForm 4 sale7,311$439k26.5%UnusualSEC